BCRX

7.2201.37%
JR

John Ruesch

Chief Technical Operations Officer

Mr. John Ruesch is Chief Technical Operations Officer of BioCryst Pharmaceuticals, Inc. from January 2026. Mr. Ruesch was Senior VP of Pharmaceutical Sciences & Technical Operations of Astria Therapeutics, Inc. from July 2023 until 2026. Previously, he was Vice President, Pharmaceutical Development at Surface Oncology from 2021 to 2023. From 2015 to 2021, Mr. Ruesch held several roles at Biogen, Inc., including Vice President, Protein Technical Development, Senior Director, Head of Protein Technical Development and Senior Director, Drug Product Development. Prior to Biogen, he worked at Pfizer from 2003 to 2015 in positions of increasing responsibility, culminating in his role as Senior Director, Formulation and Drug Product Process Development. Mr. Ruesch holds his B.S. in Biology from Valparaiso University and his M.B.A. from Northwestern University Kellogg School of Management.

Positions